These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 12051714)

  • 1. Characterisation of the phosphorylation of beta-catenin at the GSK-3 priming site Ser45.
    Hagen T; Vidal-Puig A
    Biochem Biophys Res Commun; 2002 Jun; 294(2):324-8. PubMed ID: 12051714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Axin, a negative regulator of the Wnt signaling pathway, forms a complex with GSK-3beta and beta-catenin and promotes GSK-3beta-dependent phosphorylation of beta-catenin.
    Ikeda S; Kishida S; Yamamoto H; Murai H; Koyama S; Kikuchi A
    EMBO J; 1998 Mar; 17(5):1371-84. PubMed ID: 9482734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. beta-catenin is a target for the ubiquitin-proteasome pathway.
    Aberle H; Bauer A; Stappert J; Kispert A; Kemler R
    EMBO J; 1997 Jul; 16(13):3797-804. PubMed ID: 9233789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GSK-3beta-dependent phosphorylation of adenomatous polyposis coli gene product can be modulated by beta-catenin and protein phosphatase 2A complexed with Axin.
    Ikeda S; Kishida M; Matsuura Y; Usui H; Kikuchi A
    Oncogene; 2000 Jan; 19(4):537-45. PubMed ID: 10698523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A second protein kinase CK1-mediated step negatively regulates Wnt signalling by disrupting the lymphocyte enhancer factor-1/beta-catenin complex.
    Hämmerlein A; Weiske J; Huber O
    Cell Mol Life Sci; 2005 Mar; 62(5):606-18. PubMed ID: 15747065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Threonine 41 in beta-catenin serves as a key phosphorylation relay residue in beta-catenin degradation.
    Wu G; He X
    Biochemistry; 2006 Apr; 45(16):5319-23. PubMed ID: 16618120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A GSK3beta phosphorylation site in axin modulates interaction with beta-catenin and Tcf-mediated gene expression.
    Jho Eh; Lomvardas S; Costantini F
    Biochem Biophys Res Commun; 1999 Dec; 266(1):28-35. PubMed ID: 10581160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of two novel regulated serines in the N terminus of beta-catenin.
    van Noort M; van de Wetering M; Clevers H
    Exp Cell Res; 2002 Jun; 276(2):264-72. PubMed ID: 12027456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for involvement of Wnt signaling pathway in IB-MECA mediated suppression of melanoma cells.
    Fishman P; Madi L; Bar-Yehuda S; Barer F; Del Valle L; Khalili K
    Oncogene; 2002 Jun; 21(25):4060-4. PubMed ID: 12037688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Axin prevents Wnt-3a-induced accumulation of beta-catenin.
    Kishida M; Koyama S; Kishida S; Matsubara K; Nakashima S; Higano K; Takada R; Takada S; Kikuchi A
    Oncogene; 1999 Jan; 18(4):979-85. PubMed ID: 10023673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression and characterization of GSK-3 mutants and their effect on beta-catenin phosphorylation in intact cells.
    Hagen T; Di Daniel E; Culbert AA; Reith AD
    J Biol Chem; 2002 Jun; 277(26):23330-5. PubMed ID: 11967263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased nuclear beta-catenin, tau hyperphosphorylation and neurodegeneration in GSK-3beta conditional transgenic mice.
    Lucas JJ; Hernández F; Gómez-Ramos P; Morán MA; Hen R; Avila J
    EMBO J; 2001 Jan; 20(1-2):27-39. PubMed ID: 11226152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phosphorylation and ubiquitination of oncogenic mutants of beta-catenin containing substitutions at Asp32.
    Al-Fageeh M; Li Q; Dashwood WM; Myzak MC; Dashwood RH
    Oncogene; 2004 Jun; 23(28):4839-46. PubMed ID: 15064718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lithium inhibits neurite growth and tau protein kinase I/glycogen synthase kinase-3beta-dependent phosphorylation of juvenile tau in cultured hippocampal neurons.
    Takahashi M; Yasutake K; Tomizawa K
    J Neurochem; 1999 Nov; 73(5):2073-83. PubMed ID: 10537067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sporadic medulloblastomas contain oncogenic beta-catenin mutations.
    Zurawel RH; Chiappa SA; Allen C; Raffel C
    Cancer Res; 1998 Mar; 58(5):896-9. PubMed ID: 9500446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human serum and glucocorticoid-inducible kinase-like kinase (SGKL) phosphorylates glycogen syntheses kinase 3 beta (GSK-3beta) at serine-9 through direct interaction.
    Dai F; Yu L; He H; Chen Y; Yu J; Yang Y; Xu Y; Ling W; Zhao S
    Biochem Biophys Res Commun; 2002 May; 293(4):1191-6. PubMed ID: 12054501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antipsychotics alter the protein expression levels of beta-catenin and GSK-3 in the rat medial prefrontal cortex and striatum.
    Alimohamad H; Rajakumar N; Seah YH; Rushlow W
    Biol Psychiatry; 2005 Mar; 57(5):533-42. PubMed ID: 15737669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Signal transduction: signaling specificity- a complex affair.
    Weston CR; Davis RJ
    Science; 2001 Jun; 292(5526):2439-40. PubMed ID: 11431552
    [No Abstract]   [Full Text] [Related]  

  • 19. Erk associates with and primes GSK-3beta for its inactivation resulting in upregulation of beta-catenin.
    Ding Q; Xia W; Liu JC; Yang JY; Lee DF; Xia J; Bartholomeusz G; Li Y; Pan Y; Li Z; Bargou RC; Qin J; Lai CC; Tsai FJ; Tsai CH; Hung MC
    Mol Cell; 2005 Jul; 19(2):159-70. PubMed ID: 16039586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Axin-mediated CKI phosphorylation of beta-catenin at Ser 45: a molecular switch for the Wnt pathway.
    Amit S; Hatzubai A; Birman Y; Andersen JS; Ben-Shushan E; Mann M; Ben-Neriah Y; Alkalay I
    Genes Dev; 2002 May; 16(9):1066-76. PubMed ID: 12000790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.